Skip to main content

Table 1 Patients with periprosthetic Staphylococcus infection receiving clindamycin-rifampin combination therapy

From: Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study

 

Debridement and retention

Revision

n (%)

n (%)

Number of patients

18

18

 Age, years; median (range)

71 (39 – 89)

58 (30 – 87)

 BMIa, kg/m2; median (range)

26 (20 – 32)

25 (19 – 35)

 Gender, male

12

13

Prosthesis site

 Hip

13

18

 Knee

5

0

Indication for prosthesis

 Primary arthrosis

5

3

 Secondary arthrosis

 Childhood hip disease

1

4

 Post traumatic

3

2

 Osteonecrosis

1

1

 Rheumatoid arthritis

1

0

 Hemophilia

1

0

 Revision arthroplasty

5

6

 Unknown

0

2

 Femoral neck fracture

1

0

Risk factors for PJIb / comorbidity

 Previous hip/knee surgery before primary THA/TKA

10

10

 Immune suppression

1

2

 Previous PJI

1

2

 Diabetes Mellitus

2

2

 Obesity (BMIa > 30 kg/m2)

1

3

 ASAc score; median (range)

2 (1 – 3)

2 (1 – 3)

  1. aBMI, Body Mass Index
  2. bPJI, Periprosthetic Joint Infection
  3. cASA, American Society of Anesthesiologists; THA, total hip arthroplasty; TKA, total knee arthroplasty